MedPath

Combined Laser-surgical Technology of RRD Treatment

Not Applicable
Conditions
Rhegmatogenous Retinal Detachment
Registration Number
NCT04403750
Lead Sponsor
The S.N. Fyodorov Eye Microsurgery State Institution
Brief Summary

Purpose: to assess the efficacy and safety of combined laser-surgical technology of RRD treatment

Detailed Description

The study takes place in the S.N. Fyodorov "Eye Microsurgery" Federal State Institution located in Moscow, Russian Federation.

The study will include 50 patients with rhegmatogenous retinal detachment due to a horseshoe-tear. In addition to the standard ophthalmological examination, all patients will undergo wide-field optical coherence tomography to determine the extension and localization of the vitreoretinal traction zone. The obtained data will be used to planning the 1st step of laser-surgical treatment. All patients will undergo a combined laser-surgical technology, which includes 3 steps: 1) Nd-YAG laser excision of the vitreoretinal traction zone 2) pneumatic retinopexy (10% C3F8) 3) barrier laser photocoagulation around retinal break after retinal attachment.

The patients are going to be followed up for at least 1 year, the main outcome measures are postoperative primary and final anatomic outcome, BCVA and complications.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  1. Rhegmatogenous retinal detachment extending from the 9-o'clock to the 3-o'clock meridians.
  2. Superior retinal break from 9 o'clock to 3 o'clock
  3. Single retinal break not greater than 1 clock hours in size
  4. Physically and mentally co-operated in post-operative head positioning
  5. No (or minimal) proliferative vitreoretinopathy
  6. None or mild vitreous hemorrhage.
Exclusion Criteria
  1. Severe concomitant eye pathologies (glaucoma, diabetic retinopathy, macular hole, traumas); OR
  2. Ocular media opacities
  3. Previous ocular surgeries
  4. Age <18 years
  5. Previous retinal detachment (index eye)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Retinal reattachment ratein 1 month after gas resorption

complete retinal re-attachment

Secondary Outcome Measures
NameTimeMethod
Anatomical success3, 6, 12 and 24 months post intervention

complete retinal re-attachment

Visual acuity3, 6, 12 and 24 months post intervention

Snellen

Trial Locations

Locations (1)

The S.N. Fyodorov Eye Microsurgery State Institution.

🇷🇺

Moscow, Russian Federation

The S.N. Fyodorov Eye Microsurgery State Institution.
🇷🇺Moscow, Russian Federation
Mariiam Taevere
Contact
+79160173038
Leonid Kryl, PhD, MD
Principal Investigator
Mariiam Taevere, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.